California connection delivers Johnson & Johnson-Evotec approach to Alzheimer's disease

Johnson & Johnson’s Janssen Pharmaceuticals Inc. unit is charging at Alzheimer’s disease again, this time tapping a partner to decipher genetic signals that may allow it to mount an early attack on the debilitating, memory-purging disease...